In CXCR3-deficient mouse models, breast cancer progression is accelerated, which is associated with increased M2 polarization of macrophages, suggesting that CXCR3 may play a suppressive role in regulating the tumor immune microenvironment. Here, CXCR3 is linked to breast carcinoma.